Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases
cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a …

Chronic hepatitis B virus (HBV) infection remains a leading cause of hepatic inflammation
and damage. The pathogenesis of chronic hepatitis B (CHB) infection is predominantly …

The human liver fulfills several vital tasks daily and possesses an impressive ability to self-
regenerate. However, the capacity of this self-healing process can be exhausted by a variety …

Hepatitis B virus (HBV) infection is a worldwide medical issue with significant morbidity and
mortality, as it is the main cause of chronic liver disease and hepatocellular carcinoma …

Simple Summary Hepatocellular carcinoma (HCC) still poses a major challenge for curative
treatment. Although some new therapeutic options arose during the last decade, the overall …

T helper cell 22 are abundant in Hepatitis B Virus-related hepatocellular carcinoma tissue,
and the main cytokine interleukin 22 produced by Th22 cells is closely related to the …

Atopic dermatitis (AD) is a prevalent and chronic inflammatory skin condition characterized
by a multifaceted pathophysiology that gives rise to diverse clinical manifestations. The …

Introduction Sorafenib is currently the first-line treatment for patients with advanced
hepatocellular carcinoma (HCC). Nevertheless, sorafenib resistance remains a huge …

Background Insufficient remnant liver volume (RLV) after the resection of hepatic
malignancy could lead to liver failure and mortality. Portal vein ligation (PVL) prior to …

Interleukin-22, discovered in the year of 2000, is a pleiotropic Th17 cytokine from the IL-10
family of cytokines. IL-22 signals through the type 2 cytokine receptor complex IL-22R and …